跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Mupisaph - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Mupisaph
Approved
STANDARD
Mupisaph
Azine Healthcare Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
dbe08dbefa2c39f8
Company
Azine Healthcare Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
dbe08dbefa2c39f8
Drug Approval Philippines Name
Mupisaph
Product Name
Mupisaph
Registration Number
DRP-10840
Brand Name
Mupisaph
Generic Name
Mupirocin
Dosage Form
Topical Cream
Dosage Strength
20mg/g (2% w/w)
Manufacturer
Azine Healthcare Pvt. Ltd.
Trader
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
28 December 2021
Expiry Date
28 December 2026
Classification
Over-The-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
dbe08dbefa2c39f8
Type
Standard
Back to Philippines FDA Approvals